UK shareholder meetings calendar - next 7 days
9th Feb 2023 15:46
(Alliance News) - Belluscura PLC on Friday hailed "considerable progress" in 2022, but still expects to report loss. Read More
(Alliance News) - Stock prices in London opened higher on Friday, ending a bullish week in decent fashion as cooler US inflation and unexpectedly robust UK growth figures lifted the mood. Read More
Belluscura PLC - London-based medical device developer - Enters its first international distribution agreement outside of the US, with MedHealth Supplies. Says MedHealth is a durable medical equipment provider in South Africa. MedHealth has placed orders for both 2022 and 2023, with deliveries to commence immediately. Read More
Otaq - Lancaster, England-based marine technology for offshore oil and gas industries and aquaculture - Appoints Adam Reynolds as chair, effective immediately. Reynolds is chair at medical device developer Belluscura PLC and Cardiff-based healthcare company MyHealthChecked PLC. He replaces Alex Hambro, who leaves Otaq immediately. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Belluscura PLC - London-based medical device developer - In the six months ended June 30, reports a widened pretax loss of USD4.6 million. The previous year, the firm posted a loss of USD2.4 million. Revenue in the half totals USD561,745, up from nil the previous year. Belluscura says it strengthened its manufacturing capacity, secured its supply chain and reduced its production costs during the half. Looking forward, focus is on the completion of the development and testing of its next product, DISCOV-R, a portable oxygen concentrator. Chair Adam Reynolds adds the firm expects "substantial growth" over the coming years. Read More
Belluscura PLC - London-based medical device developer - Enters into an agreement for the supply of portable oxygen concentrators with VGM Group Inc. Says that VGM is "largest and most comprehensive" member service organisation in the US for post-acute healthcare. Over 2,500 healthcare providers with nearly 7,000 locations across the US rely on VGM to supply them with healthcare resources, it adds. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Belluscura PLC - London-based medical device developer - Increases the size of the GBP5 million placing that was announced on Thursday, as it was "significantly" oversubscribed. Raises GBP6 million through the placing of 7.1 million shares at 85 pence per share. Says the placing price represents a 15% discount to the closing mid-market price on Thursday. Says the placing shares represent roughly 6.2% of its existing share capital. Notes that Dowgate Capital Ltd acted as sole broker and bookrunner. Plans to use the proceeds to fund the purchase of raw material inventory and for manufacturing non-recurring engineering costs in connection to its recently announced global manufacturing deal with InnoMax Medical Technology Ltd. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The FTSE 100 was able to outperform European peers on Wednesday - a reversal from Tuesday - as the commodity-heavy index was getting a lift from oil companies and miners. Read More
Belluscura PLC - London-based medical device developer - Signs a manufacturing master supply agreement with InnoMax Medical Technology Ltd, a joint venture between MexNerva Technology Services Ltd and China's National Centre for Advanced Medical Devices. The agreement is for the manufacture of the X-PLO2R portable oxygen concentrator in China. Belluscura says the agreement will more than double its manufacturing capacity next year. Commercialisation and distribution in Asia is expected to occur no later than the first quarter of 2023. The agreement has an initial duration of three years. Belluscura does not disclose the financial details. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Belluscura shares drop on inventory build-up due to supply chain issue Read More
IN BRIEF: Belluscura gets 2nd US Medicare approval for oxygen machine Read More